Targeted Genetics, Novartis deal

Novartis subsidiaries Genetic Therapy Inc. (Gaithersburg, Md.) and SyStemix Inc. (Palo Alto, Calif.) received a non-exclusive, worldwide sublicense to TGEN's T7 gene expression technology. TGEN has ...